A fetal intervention team led by Ramesha Papanna, MD, MPH, of The University of Texas Health Science Center at Houston (UTHealth) has received a $3.2 million award from the National Institutes of Health (NIH) for preclinical research on a new approach to repair spina bifida in utero.

Black and Hispanic patients develop more disability from multiple sclerosis (MS) and respond to treatments for the disease differently compared to white patients who also have the disease, according to recent findings presented by researchers at UTHealth. 

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson's disease has been launched at The University of Texas Health Science Center at Houston (UTHealth). 

The University of Texas Health Science Center at Houston (UTHealth) publicly launched its first comprehensive campaign Many Faces. One Mission. on Thursday, April 8. The campaign, representing the largest philanthropic effort in UTHealth’s history, aims to raise $500 million to address pressing health challenges and secure the institution’s future as a top health science center. Since the campaign’s quiet phase began in 2015, UTHealth’s closest friends have given more than $400 million in gifts and pledges.

The John S. Dunn Foundation has made a transformative $25 million commitment to The University of Texas Health Science Center at Houston (UTHealth) to bolster the university’s behavioral health initiatives and address significant gaps in mental health care services in our communities.

A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.

Researchers are using a novel health platform that links them to shared electronic health records from consented patients to track long-term effects of COVID-19 in a new study by UTHealth. 

Stroke patients received clot-busting medications such as tissue plasminogen activator (tPA) faster, more often, and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to researchers with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center (TMC).

Researchers with The University of Texas Health Science Center at Houston (UTHealth) have created an acronym, RAPIDO™, to move forward much-needed efforts to address stroke sign and symptom awareness among at-risk Spanish-speaking individuals.

Treating patients with stem cells from their own bone marrow could lead to a reduction in brain injury after a stroke caused by a blood clot, according to research by The University of Texas Health Science Center at Houston (UTHealth).

Projections from Texas’ first cardiac arrest registry show that every day at least 60 Texans will suffer an out-of-hospital cardiac arrest, which is a sudden loss of heart function, breathing, and consciousness. If bystander cardiopulmonary resuscitation (CPR) is performed, the victim’s chance of survival can triple, but less than half of victims in the Lone Star State receive any bystander CPR, according to data from the registry.

Dropping out of high school, having schizophrenia, or being diagnosed with a co-occurring personality disorder increases the likelihood of someone becoming a “high utilizer” of inpatient psychiatric hospital services, according to a new study by researchers at UTHealth. A high utilizer is someone who has been admitted three or more times within one year.

A clinical trial to assess the safety and efficacy of stem cell therapy for treatment-resistant bipolar depression launched recently at The University of Texas Health Science Center at Houston (UTHealth).

A $4 million subcontract grant for scientists to collect COVID-19 data from virus researchers across the country in order to develop a data coordinating center has been awarded to researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics.

A pain management regimen comprised mostly of over-the-counter medication reduced opioid exposure in trauma patients while achieving equal levels of pain control, according to a new study by physician-researchers at The University of Texas Health Science Center at Houston (UTHealth).

Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.

A lack of a protein in the brain that keeps our tissues healthy as we age is linked to Alzheimer’s disease, according to recent research from The University of Texas Health Science Center at Houston (UTHealth).

Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million in funding from the U.S. Department of Defense (DOD) to expand the Phase II clinical trial at UTHealth. 

Using human-induced pluripotent stem cells engineered from a single family’s blood samples, a gene signaling pathway linked to a higher risk for developing schizophrenia was discovered by scientists at UTHealth. The research was published in a recent issue of Neuropsychopharmacology.

Unraveling the links among obesity, aging, telomere lengths and metabolic diseases is the subject of the study published today in Nature Metabolism by a collaborative research team at The University of Texas Health Science Center at Houston (UTHealth).

A pattern in how the brain breaks down tryptophan, a common amino acid consumed through food, was discovered by researchers at UTHealth. The finding, which could help physicians more accurately diagnose and treat several major mental health disorders, was recently published in Molecular Psychiatry.

Researchers are investigating whether a human umbilical cord patch placed on the spina bifida defect could improve healing after minimally invasive fetoscopic surgery in a clinical trial at The University of Texas Health Science Center at Houston (UTHealth).

When medically complex children are hospitalized, linking hospitalists to their regular outpatient providers through an inpatient consultation service were more likely to improve outcomes, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

The uniquely human ability to read is the cornerstone of modern civilization, yet very little is understood about the effortless ability to derive meaning from written words. Scientists at UTHealth have now identified a crucial region in the temporal lobe, know as the mid-fusiform cortex, which appears to act as the brain’s visual dictionary.